Drug Profile
Omeprazole/sodium bicarbonate powder suspension - Salix Pharmaceuticals
Alternative Names: Acitrel; Omez Insta; Rapinex Powder for Oral Suspension; SAN 05; Zegerid Powder for Oral SuspensionLatest Information Update: 07 Apr 2015
Price :
$50
*
At a glance
- Originator Santarus
- Developer Norgine; Salix Pharmaceuticals
- Class 2 pyridinylmethylsulfinylbenzimidazoles; Alkalinising agents; Antiulcers; Gastric antisecretories; Small molecules; Sodium compounds
- Mechanism of Action Antacids; Proton pump inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Duodenal ulcer; Erosive oesophagitis; Gastric ulcer; Gastritis; Gastro-oesophageal reflux; Gastrointestinal haemorrhage
Most Recent Events
- 01 Apr 2015 Salix Pharmaceuticals has been acquired by Valeant Pharmaceuticals International
- 02 Jan 2014 Santarus has been acquired and merged into Salix Pharmaceuticals
- 01 Feb 2011 Norgine completes a Phase-I trial in Duodenal ulcer, Erosive oesophagitis and Gastro-oesophageal reflux (in volunteers) in United Kingdom (NCT01710995)